219 related articles for article (PubMed ID: 14990704)
1. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.
Taylor SL; Kinchington PR; Brooks A; Moffat JF
J Virol; 2004 Mar; 78(6):2853-62. PubMed ID: 14990704
[TBL] [Abstract][Full Text] [Related]
2. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
Rowe J; Greenblatt RJ; Liu D; Moffat JF
Antiviral Res; 2010 Jun; 86(3):276-85. PubMed ID: 20307580
[TBL] [Abstract][Full Text] [Related]
3. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.
Schang LM; Rosenberg A; Schaffer PA
J Virol; 2000 Mar; 74(5):2107-20. PubMed ID: 10666240
[TBL] [Abstract][Full Text] [Related]
4. Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis.
Moffat JF; McMichael MA; Leisenfelder SA; Taylor SL
Biochim Biophys Acta; 2004 Mar; 1697(1-2):225-31. PubMed ID: 15023363
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
Habran L; Bontems S; Di Valentin E; Sadzot-Delvaux C; Piette J
J Biol Chem; 2005 Aug; 280(32):29135-43. PubMed ID: 15955820
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.
Davido DJ; Leib DA; Schaffer PA
J Virol; 2002 Feb; 76(3):1077-88. PubMed ID: 11773384
[TBL] [Abstract][Full Text] [Related]
7. The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0.
Davido DJ; Von Zagorski WF; Maul GG; Schaffer PA
J Virol; 2003 Dec; 77(23):12603-16. PubMed ID: 14610183
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.
Wang D; de la Fuente C; Deng L; Wang L; Zilberman I; Eadie C; Healey M; Stein D; Denny T; Harrison LE; Meijer L; Kashanchi F
J Virol; 2001 Aug; 75(16):7266-79. PubMed ID: 11461999
[TBL] [Abstract][Full Text] [Related]
9. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
Schang LM; Phillips J; Schaffer PA
J Virol; 1998 Jul; 72(7):5626-37. PubMed ID: 9621021
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibition of varicella-zoster virus replication in vitro.
Docherty JJ; Sweet TJ; Bailey E; Faith SA; Booth T
Antiviral Res; 2006 Dec; 72(3):171-7. PubMed ID: 16899306
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions.
Leisenfelder SA; Kinchington PR; Moffat JF
J Virol; 2008 Dec; 82(24):12116-25. PubMed ID: 18799590
[TBL] [Abstract][Full Text] [Related]
12. Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.
Shakya AK; O'Callaghan DJ; Kim SK
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918075
[TBL] [Abstract][Full Text] [Related]
13. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
Schang LM; Rosenberg A; Schaffer PA
J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.
Schang LM
Biochim Biophys Acta; 2004 Mar; 1697(1-2):197-209. PubMed ID: 15023361
[TBL] [Abstract][Full Text] [Related]
15. Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.
Diwan P; Lacasse JJ; Schang LM
J Virol; 2004 Sep; 78(17):9352-65. PubMed ID: 15308730
[TBL] [Abstract][Full Text] [Related]
16. Cdk inhibitory nucleoside analogs prevent transcription from viral genomes.
Schang LM; Coccaro E; Lacasse JJ
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):829-37. PubMed ID: 16248044
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological cdk inhibitor R-Roscovitine suppresses JC virus proliferation.
Orba Y; Sunden Y; Suzuki T; Nagashima K; Kimura T; Tanaka S; Sawa H
Virology; 2008 Jan; 370(1):173-83. PubMed ID: 17919676
[TBL] [Abstract][Full Text] [Related]
18. Honeysuckle-derived microRNA2911 directly inhibits varicella-zoster virus replication by targeting IE62 gene.
Huang Y; Liu H; Sun X; Ding M; Tao G; Li X
J Neurovirol; 2019 Aug; 25(4):457-463. PubMed ID: 31140131
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
Majima R; Shindoh K; Yamaguchi T; Inoue N
Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
[TBL] [Abstract][Full Text] [Related]
20. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
